Primecap Management Co. CA Grows Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT)

Key Points

• Primecap Management Co. CA increased its stake in Health Catalyst, Inc. by 3.8% during the 1st quarter, owning 2,005,116 shares valued at approximately $9,083,000.
• Institutional investors hold 85% of Health Catalyst's stock, indicating strong interest from large financiers.
• Analysts have mixed opinions on Health Catalyst's stock price targets, with estimates varying from $4.00 to $9.00, and an average consensus rating of "Moderate Buy."

Primecap Management Co. CA increased its stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 3.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,005,116 shares of the company's stock after purchasing an additional 72,499 shares during the quarter. Primecap Management Co. CA owned 2.86% of Health Catalyst worth $9,083,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Group One Trading LLC boosted its stake in shares of Health Catalyst by 107.6% in the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company's stock worth $31,000 after buying an additional 2,260 shares during the last quarter. XTX Topco Ltd bought a new position in Health Catalyst in the first quarter valued at about $54,000. Aquatic Capital Management LLC purchased a new position in Health Catalyst in the fourth quarter worth about $63,000. Brevan Howard Capital Management LP purchased a new position in Health Catalyst in the fourth quarter worth about $92,000. Finally, ExodusPoint Capital Management LP bought a new stake in shares of Health Catalyst during the 4th quarter valued at about $107,000. Institutional investors own 85.00% of the company's stock.

Health Catalyst Price Performance

Shares of Health Catalyst stock opened at $3.69 on Friday. The company has a market capitalization of $256.82 million, a price-to-earnings ratio of -3.21 and a beta of 1.46. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.40. The stock's 50-day simple moving average is $3.86 and its 200-day simple moving average is $4.29. Health Catalyst, Inc. has a 52 week low of $3.48 and a 52 week high of $9.24.

Analysts Set New Price Targets

HCAT has been the topic of a number of research reports. KeyCorp dropped their price objective on shares of Health Catalyst from $7.00 to $5.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Stifel Nicolaus boosted their price objective on shares of Health Catalyst from $5.00 to $5.50 and gave the company a "hold" rating in a research report on Thursday, May 8th. Citigroup reduced their price objective on Health Catalyst from $7.00 to $6.50 and set a "buy" rating for the company in a research note on Friday, April 25th. Canaccord Genuity Group lowered their target price on Health Catalyst from $10.00 to $9.00 and set a "buy" rating on the stock in a research report on Thursday, May 8th. Finally, Evercore ISI reduced their price target on Health Catalyst from $5.00 to $4.00 and set an "in-line" rating for the company in a research report on Wednesday, July 9th. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $8.00.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

Want to see what other hedge funds are holding HCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Health Catalyst, Inc. (NASDAQ:HCAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.